RNA Stock-Based Compensation
Atrium Therapeutics Inc · Stock-Based Compensation
RNA Stock-Based Compensation
Latest reported$0.00period ending
RNA Quarterly Stock-Based Comp ($3.55M → $0.00)
Quarterly stock-based compensation
High-resolution chart · PNG
RNA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 0 | |
| 3,552,000 |